Full Year 2021 Oncimmune Holdings PLC Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Oncimmune Holdings full year results investor presentation. (Operator Instructions) I'd also like to remind you that this presentation is being recorded. Before we begin, we'd like to submit the following poll. And if you give that your kind attention, we would be most grateful. And I'd now like to hand over to Matthew Hall, CFO; and Dr. Adam Hill, CEO from Oncimmune. Good afternoon.
Many thanks for joining us. Ladies and gentlemen, my name's Adam Hill, and I'm joined by Matthew Hall. We've both been with the company for approximately 3.5 years during which we've led very much a turnaround of Oncimmune, and focused the company not just upon early detection but also upon the support of pharmaceutical companies that are currently pursuing clinical trials, and that second part of the business is very much the growth catalyst for us moving forward.
I'm going to spend the next couple of minutes just talking about what we've achieved over the reporting period and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |